[1] |
FU Xiaoyu, KONG Deguang, LI Juanjuan.
Treatment progress of triple positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
|
[2] |
CHEN Qun, ZHU Heping, YUAN Xiaolong.
Analysis of 197 cases of pentoxifylline injection and exploring supervision mode of rational drug use in hospitals
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 948-953.
|
[3] |
FAN Jie, JIN Yongming, JIANG Xiaolong, JIANG Guohua.
Molecular mechanism of lncRNA HOTAIR regulating miR-206 on the proliferation and apoptosis of rheumatoid arthritis synovial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 736-742.
|
[4] |
XU Xiuhe, HE Xiaoli, ZHOU Jiashun, PAN Lizhu, ZHOU Zhuojun, LI Jiayue, WANG Caixia, YUAN Wei, ZHU Guiqi.
Effects of scacia honey on serum uric acid level and renal injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 743-750.
|
[5] |
WANG Lin, YU Jianguo, LI Xiao, LUAN Jiajie.
Establish and implement a pre-prescription system for outpatient based on Six Sigma DMAIC model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 780-787.
|
[6] |
WANG Anjing, WANG Yaya, LIANG Xuan, YAN Yajie, SU Jing, LI Caidong.
Research progress on mechanisms and therapeutic drugs of peroxisome proliferator-activated receptor in treatment of cholestatic liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 796-808.
|
[7] |
ZHAO Lingzhi, HE Yanjun, XIE Jianqin, YOU Chongge.
Research progress on therapeutic role of recombinant human soluble thrombomodulin in atherosclerosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 832-840.
|
[8] |
WANG Donghui, JIANG Suwen, HU Airong, ZHU Bo, HE Zheyun, ZHANG Lukan, WANG Jialan, FAN Ying, LIN Ken .
Mulberry exerts antioxidant stress effect in rats with nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 609-616.
|
[9] |
LI Hongqin, CAO Limin, JIN Manyi, WANG Jianlong, CHAI Xiaoping, TIAN Miaomiao.
Effects of different dosage forms of Qianzheng powder on facial nerve injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 617-623.
|
[10] |
ZHANG Wei, LIU Lei, GUAN Shaoyang, SHENG Zhao, SUN Wenwen.
Analysis of the diagnostic value of fine-needle aspiration cytology and BRAF and RAS gene mutation screening for thyroid cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 653-657.
|
[11] |
WU Xiongzhi, WANG Xuan, XU Siqi, JU Xia, WANG Shengbin, CHEN Yongquan.
A comparative investigation of the impact of oral midazolam solution and dexmedetomidine nasal spray on preoperative anxiety in pediatric patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 666-670.
|
[12] |
QIAO Hongliang, DING Ning, DENG Kaihong, LIU Binbin, DONG Chuanjiang, CHEN Xiaobo, ZOU Lili.
New progress in research on novel control strategies for methicillin-resistant staphylococcus aureus infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 676-687.
|
[13] |
CHEN Cheng, DENG Yu, GONG Youlan, ZHANG Zhenming, DUAN Wulei, QING Jun, ZHANG Bo.
Research progress of the classical TCM formula Huaihua powder
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 697-704.
|
[14] |
WANG Yan, ZHANG Jinhui, ZHAO Yongchen, LIU Hongxiang, LIU Yawei, MIAO Huanhuan, YANG Xincai.
Sequoiaflavone inhibits stem cell properties such as proliferation and invasion of gastric cancer cells by down-regulating PI3K/AKT signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 508-513.
|
[15] |
DANG Zilong, LIU Haiyang, ZHANG Yangfan, LIU Jinfeng, ZHANG Tianwei, LI Bin, GUO Hong, CHENG Wenyuan, XU Xiaohui, LI Yile, WEI Yuhui, WU Xin'an.
Optimization strategy of antibiotic dosing regimen in intensive care unit patients with augmented renal clearance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 561-571.
|